This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
05/06/15 - 3:27:56 PM ET (BATS BZX Real-time Price)
Div Yield: --
IPCI Day's Range
IPCI 52 Week Range
IPCI Business Summary
Intellipharmaceutics International Inc., a pharmaceutical company, engages in the research, development, and manufacture of novel and generic controlled and targeted release oral solid dosage drugs in Canada.View IPCI key stats
IntelliPharmaCeutics International Inc - IPCI - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates IntelliPharmaCeutics International Inc as a
Hold with a ratings score of C.
Report Snippet: We rate INTELLIPHARMACEUTICS INTL (IPCI) a HOLD. The primary factors that have impacted our rating are mixed - some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. Among the primary strengths of the company is its solid financial position based on a variety of debt and liquidity measures that we have evaluated. At the same time, however, we also find weaknesses including unimpressive growth in net income, disappointing return on equity and weak operating cash flow.